Text Size

Relevance of Lipid-Based Products in the Management of Dry Eye Disease

Garrigue J.-S., Amrane M., Faure M.-O., Holopainen J.M., Tong L.

  • 2017
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology


  • Affiliations

    Santen SAS, RandD Innovation Center, 1 rue Pierre Fontaine, Evry, 91000, France; Scientific Consulting for You, Paris, France; Helsinki Eye Lab, Ophthalmology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland; Singapore Eye Research Institute, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Singapore National Eye Center, Singapore, Singapore

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022